Palavra-chave: PRAZIQUANTEL

CICLODEXTRINA DRUG DELIVERY BETA-CICLODEXTRINA STRAINS TEGUMENT SCHISTOSOMIASIS METILBETACICLODEXTRINA BLENDAS DRUG-DELIVERY INCLUSION COMPLEX PZQ-RESISTANT METHYL BETA CYCLODEXTRIN CÃES RESISTANCE SCHISTOSOMA MANSONI COMPLEXO DE INCLUSÃO NANOPARTÍCULAS LIPÍDICAS SÓLIDAS LIPOSOMES MOLECULAR MODELING LIPIDS DRUG DELIVERY SYSTEM MALDI-MSI HEPG2 CELLS MORPHOLOGY COMPLEX INCLUSION NANOTECHNOLOGY PIRANTEL TRATAMENTO CYCLODEXTRIN LIPOSSOMAS BIOMARKERS RESISTENCE NUCLEAR MAGNETIC RESONANCE SOLID LIPID NANOPARTICLES SCHISTOSOMIASIS MANSONI BIOMARCADORES SCHISTOSOMA MANSONI, FEBANTEL ANTIPARASITÁRIO MASS SPECTROMETRY IMAGING LIPIDEOS CYTOTOXICITY NANOSTRUCTURED LIPID CARRIERS HIPERBÁRICA BIOLOGICAL ACTIVITY MOLECULAR MODELLING LIBERAÇÃO CONTROLADA DE DROGAS RESISTÊNCIA BLENDAS DE DEXTRANO SHISTOSOMÍASE CICLODEXTRINAS IN VITRO ESQUISTOSSOMOSE SHISTOSOMIASIS NMR